193 related articles for article (PubMed ID: 18570646)
1. A computational analysis of protein-protein interaction networks in neurodegenerative diseases.
Goñi J; Esteban FJ; de Mendizábal NV; Sepulcre J; Ardanza-Trevijano S; Agirrezabal I; Villoslada P
BMC Syst Biol; 2008 Jun; 2():52. PubMed ID: 18570646
[TBL] [Abstract][Full Text] [Related]
2. Identification of key target genes and biological pathways in multiple sclerosis brains using microarray data obtained from the Gene Expression Omnibus database.
Zheng W; Chen Y; Chen H; Xiao W; Liang Y; Wang N; Jiang X; Wen S
Neurol Res; 2018 Oct; 40(10):883-891. PubMed ID: 30074468
[TBL] [Abstract][Full Text] [Related]
3. Differential Expression of mRNAs in the Brain Tissues of Patients with Alzheimer's Disease Based on GEO Expression Profile and Its Clinical Significance.
Ma G; Liu M; Du K; Zhong X; Gong S; Jiao L; Wei M
Biomed Res Int; 2019; 2019():8179145. PubMed ID: 30918899
[TBL] [Abstract][Full Text] [Related]
4. Integrated identification of key genes and pathways in Alzheimer's disease via comprehensive bioinformatical analyses.
Yan T; Ding F; Zhao Y
Hereditas; 2019; 156():25. PubMed ID: 31346329
[TBL] [Abstract][Full Text] [Related]
5. Abundant kif21b is associated with accelerated progression in neurodegenerative diseases.
Kreft KL; van Meurs M; Wierenga-Wolf AF; Melief MJ; van Strien ME; Hol EM; Oostra BA; Laman JD; Hintzen RQ
Acta Neuropathol Commun; 2014 Oct; 2():144. PubMed ID: 25274010
[TBL] [Abstract][Full Text] [Related]
6. Integrating single-nucleus sequence profiling to reveal the transcriptional dynamics of Alzheimer's disease, Parkinson's disease, and multiple sclerosis.
Fan LY; Yang J; Liu RY; Kong Y; Guo GY; Xu YM
J Transl Med; 2023 Sep; 21(1):649. PubMed ID: 37735671
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive analysis on preservation patterns of gene co-expression networks during Alzheimer's disease progression.
Ray S; Hossain SMM; Khatun L; Mukhopadhyay A
BMC Bioinformatics; 2017 Dec; 18(1):579. PubMed ID: 29262769
[TBL] [Abstract][Full Text] [Related]
8. Identification of Key Regulatory Genes and Pathways in Prefrontal Cortex of Alzheimer's Disease.
Yang F; Diao X; Wang F; Wang Q; Sun J; Zhou Y; Xie J
Interdiscip Sci; 2020 Mar; 12(1):90-98. PubMed ID: 32006383
[TBL] [Abstract][Full Text] [Related]
9. Computational studies on Alzheimer's disease associated pathways and regulatory patterns using microarray gene expression and network data: revealed association with aging and other diseases.
Panigrahi PP; Singh TR
J Theor Biol; 2013 Oct; 334():109-21. PubMed ID: 23811083
[TBL] [Abstract][Full Text] [Related]
10. Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach.
Hu YS; Xin J; Hu Y; Zhang L; Wang J
Alzheimers Res Ther; 2017 Apr; 9(1):29. PubMed ID: 28446202
[TBL] [Abstract][Full Text] [Related]
11. Identification of the Hub Genes in Alzheimer's Disease.
Gui H; Gong Q; Jiang J; Liu M; Li H
Comput Math Methods Med; 2021; 2021():6329041. PubMed ID: 34326892
[TBL] [Abstract][Full Text] [Related]
12. Construction and analysis of the protein-protein interaction networks based on gene expression profiles of Parkinson's disease.
Rakshit H; Rathi N; Roy D
PLoS One; 2014; 9(8):e103047. PubMed ID: 25170921
[TBL] [Abstract][Full Text] [Related]
13. Identification of viral-mediated pathogenic mechanisms in neurodegenerative diseases using network-based approaches.
Onisiforou A; Spyrou GM
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34237135
[TBL] [Abstract][Full Text] [Related]
14. Information flow analysis of interactome networks.
Missiuro PV; Liu K; Zou L; Ross BC; Zhao G; Liu JS; Ge H
PLoS Comput Biol; 2009 Apr; 5(4):e1000350. PubMed ID: 19503817
[TBL] [Abstract][Full Text] [Related]
15. Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases.
Allen M; Wang X; Burgess JD; Watzlawik J; Serie DJ; Younkin CS; Nguyen T; Malphrus KG; Lincoln S; Carrasquillo MM; Ho C; Chakrabarty P; Strickland S; Murray ME; Swarup V; Geschwind DH; Seyfried NT; Dammer EB; Lah JJ; Levey AI; Golde TE; Funk C; Li H; Price ND; Petersen RC; Graff-Radford NR; Younkin SG; Dickson DW; Crook JR; Asmann YW; Ertekin-Taner N
Alzheimers Dement; 2018 Mar; 14(3):352-366. PubMed ID: 29107053
[TBL] [Abstract][Full Text] [Related]
16. Graph analysis of structural brain networks in Alzheimer's disease: beyond small world properties.
John M; Ikuta T; Ferbinteanu J
Brain Struct Funct; 2017 Mar; 222(2):923-942. PubMed ID: 27357309
[TBL] [Abstract][Full Text] [Related]
17. Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy.
Cope TE; Rittman T; Borchert RJ; Jones PS; Vatansever D; Allinson K; Passamonti L; Vazquez Rodriguez P; Bevan-Jones WR; O'Brien JT; Rowe JB
Brain; 2018 Feb; 141(2):550-567. PubMed ID: 29293892
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of miRNA and mRNA expression in the blood of patients with Alzheimer's disease.
Wang Z; Shen L; Wang Y; Huang S
Mol Med Rep; 2020 Aug; 22(2):1053-1062. PubMed ID: 32468026
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.
Mahajan UV; Varma VR; Griswold ME; Blackshear CT; An Y; Oommen AM; Varma S; Troncoso JC; Pletnikova O; O'Brien R; Hohman TJ; Legido-Quigley C; Thambisetty M
PLoS Med; 2020 Jan; 17(1):e1003012. PubMed ID: 31978055
[TBL] [Abstract][Full Text] [Related]
20. Linking the association between circRNAs and Alzheimer's disease progression by multi-tissue circular RNA characterization.
Lo I; Hill J; Vilhjálmsson BJ; Kjems J
RNA Biol; 2020 Dec; 17(12):1789-1797. PubMed ID: 32618510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
